Your session is about to expire
← Back to Search
BrainGate2 System for Quadriplegia (BG-Speech-01 Trial)
BG-Speech-01 Trial Summary
This trial aims to show that people with tetraplegia can use their thoughts to control a computer and other devices, increasing independence.
BG-Speech-01 Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBG-Speech-01 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BG-Speech-01 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have ALS and cannot speak or have severe speech difficulties that have worsened recently.I can communicate clearly or have a reliable way to communicate.I have been diagnosed with ALS by a neurology specialist.I have paralysis that affects all four of my limbs.Your doctor believes you will live for at least 6 more months.I am between 18 and 80 years old.
- Group 1: BrainGate Neural Interface System
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For whom is enrollment open for this clinical trial?
"This clinical trial is seeking two human volunteers aged between 18 and 75 with a definitive diagnosis of locked-in syndrome. Additionally, candidates must have been diagnosed with amyotrophic lateral sclerosis (ALS) accompanied by anarthria or pronounced dysarthria that has worsened in the previous four months."
Is the enrollment period for this clinical trial still active?
"Affirmative. Clinicaltrials.gov verifies that the trial, which debuted on March 21st 2023, is still enrolling participants. An estimated 2 people need to be sourced from two sites for this research study."
To what extent is the recruitment pool expanding for this research project?
"Confirmed. According to clinicaltrials.gov, this trial that was launched on the 21st of March 2023 is still recruiting participants from two locations with a total goal of 2 enrolments."
Is the enrollment for this trial restricted by age, and if so, at what threshold?
"The minimum age for enrolment in this clinical trial is 18 and the maximum age limit is 75, as outlined in the eligibility criteria."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger